Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00491431
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
142 | CARBIDOPA | A,B | 1JS3 | 0.75 |  |
YTT | (3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine- 2,5-dione | A | 3G5H | 0.71 | |
K05 | (E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN- 1-YL)METHYLENE]BENZOHYDRAZIDE | A,B | 2I5J | 0.76 | |
1BA | 4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE | A | 2GPP | 0.72 | |
DTY | D-TYROSINE | A | 1C4B | 0.71 | |
| DTY | D-TYROSINE | A,L | 1ZEA | 0.71 | |
| DTY | D-TYROSINE | A,B,C,D,E,F, G,H | 1OF6 | 0.71 | |
| DTY | D-TYROSINE | A,B | 1UNO | 0.71 | |
| DTY | D-TYROSINE | A | 2IGZ | 0.71 | |
| DTY | D-TYROSINE | A,B,C,H,K,L | 2R5D | 0.71 | |
| DTY | D-TYROSINE | A,B | 2Q33 | 0.71 | |
| DTY | D-TYROSINE | H,S | 2H9E | 0.71 | |
| DTY | D-TYROSINE | A,B,C,H,K,L | 2R5B | 0.71 | |
| DTY | D-TYROSINE | A | 2IH0 | 0.71 | |
| DTY | D-TYROSINE | A | 1D7T | 0.71 | |
| DTY | D-TYROSINE | A,B | 1XA0 | 0.71 | |
DAH | 3,4-DIHYDROXYPHENYLALANINE | A,B | 1RNR | 0.74 | |
| DAH | 3,4-DIHYDROXYPHENYLALANINE | A | 6PAH | 0.74 | |
| DAH | 3,4-DIHYDROXYPHENYLALANINE | A,B | 1IVV | 0.74 | |
TYB | TYROSINAL | A,B | 1KDZ | 0.71 | |
| TYB | TYROSINAL | A | 1Q11 | 0.71 | |
| TYB | TYROSINAL | A,B | 2J5B | 0.71 | |
| TYB | TYROSINAL | A,I | 1GA4 | 0.71 | |
| TYB | TYROSINAL | A,B,C | 1NLU | 0.71 | |
| TYB | TYROSINAL | A,B | 1KE1 | 0.71 | |
| TYB | TYROSINAL | A,B | 1H3F | 0.71 | |
| TYB | TYROSINAL | A,B | 1H3E | 0.71 | |
4BB | 4-tert-butyl-N'-[(1E)-(3,5-dibromo- 2,4-dihydroxyphenyl)methylidene]benzohydrazide | A,B,C,D,E,F | 3DP3 | 0.72 | |
Y13 | (2E)-3-(3,4-DIHYDROXYPHENYL)-N- [2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE | A | 2EW6 | 0.74 | |
LDP | L-DOPAMINE | A,B | 2A3R | 0.74 | |
| LDP | L-DOPAMINE | A | 5PAH | 0.74 | |
| LDP | L-DOPAMINE | A,B | 2QMZ | 0.74 | |
| LDP | L-DOPAMINE | A,B | 2VQ5 | 0.74 | |
B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A | 3HF0 | 0.72 | |
| B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A | 2OXK | 0.72 | |
| B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A,B,C | 2OXJ | 0.72 | |
MTY | META-TYROSINE | A | 2TOH | 0.72 | |
| MTY | META-TYROSINE | A,B | 1BIQ | 0.72 | |
| MTY | META-TYROSINE | A | 1Q7O | 0.72 | |
SGI | 3-(4-hydroxyphenyl)propanamide | A,B | 2R9K | 0.76 | |
OX4 | 3-FLUORO-4-HYDROXYBENZALDEHYDE O- (CYCLOHEXYLCARBONYL)OXIME | A,B,C | 2OOW | 0.73 | |
BPY | BIPHENYL-2,3-DIOL | A | 1KMY | 0.71 | |
| BPY | BIPHENYL-2,3-DIOL | B | 1KW8 | 0.71 | |
| BPY | BIPHENYL-2,3-DIOL | A | 2EI3 | 0.71 | |
| BPY | BIPHENYL-2,3-DIOL | A | 1EIR | 0.71 | |
| BPY | BIPHENYL-2,3-DIOL | B | 1KW6 | 0.71 | |
| BPY | BIPHENYL-2,3-DIOL | B | 1KWC | 0.71 | |
| BPY | BIPHENYL-2,3-DIOL | B | 1KW9 | 0.71 | |
3BE | 3-bromo-N'-[(1E)-(3,5-dibromo-2,4- dihydroxyphenyl)methylidene]benzohydrazide | A,B,C,D,E,F | 3DOZ | 0.73 | |
TYC | L-TYROSINAMIDE | A | 2BF9 | 0.75 | |
| TYC | L-TYROSINAMIDE | A | 2OCI | 0.75 | |
TY3 | 3-HYDROXY-L-TYROSINE | A,B | 2VH3 | 0.74 | |
IM3 | (2E)-3-(3,4-DIHYDROXYPHENYL)-2- IMINOPROPANOIC ACID | A,B,C,D | 2E82 | 0.74 | |
OX3 | 4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME | A,B,C | 2OOH | 0.75 | |
DB1 | 2,3-DIHYDROXYBENZAMIDE | A,B,C | 1X71 | 0.71 | |
4BE | 4-bromo-N'-[(1E)-(3,5-dibromo-2,4- dihydroxyphenyl)methylidene]benzohydrazide | A,B,C,D,E,F | 3DP2 | 0.72 | |